28 Stocks Moving In Thursday's Pre-Market Session

Gainers

• Bellicum Pharmaceuticals, Inc. BLCM rose 26.3 percent to $8.65 in pre-market trading after the company disclosed that the FDA has lifted its hold on BPX-501 study.
• CYREN Ltd. CYRN rose 23.4 percent to $2.90 in pre-market trading after the company reported signing of a material contract with one of the world's largest tech companies.
• QuinStreet, Inc. QNST rose 13.4 percent to $11.50 in pre-market trading after the company reported preliminary Q3 sales results ahead of estimates. Sales are expected to come in at $115 million, beating estimates by $23 million.
• Reata Pharmaceuticals Inc RETA rose 11.6 percent to $23.50 in pre-market trading on news that the company's Bardoxolone treatment produced significant increase in Kidney function through week 36 in the Phase 2 portion of the Cardinal study.
• Ingersoll-Rand Plc IR shares rose 10.3 percent to $92.23 in pre-market trading. Ingersoll Rand disclosed that it has achieved 2020 energy efficiency goal and is advancing climate commitment with renewable energy.
• Holly Energy Partners, L.P. HEP rose 10.3 percent to $31.40 in pre-market trading after gaining 1.32 percent on Wednesday.
• Riot Blockchain, Inc. RIOT rose 7.6 percent to $7.12 in pre-market trading after gaining 2.00 percent on Wednesday.
• Therapix Biosciences Ltd. TRPX shares rose 6.4 percent to $5.35 in pre-market trading after falling 5.63 percent on Wednesday.
• HubSpot, Inc. HUBS shares rose 6.3 percent to $118.80 in the pre-market trading session.
• TechnipFMC plc FTI shares rose 5.2 percent to $32.97 in pre-market trading after gaining 3.06 percent on Wednesday.
• Essendant Inc. ESND rose 5.1 percent to $8.90 in pre-market trading. Essendant and Genuine Parts reported a combination of SP Richards unit.
• Mobil'nye Telesistemy PAO (ADR) MBT rose 5.2 percent to $10.40 in pre-market trading after falling 3.42 percent on Wednesday.
• Aileron Therapeutics, Inc. ALRN rose 5.1 percent to $7.50 in pre-market trading after gaining 11.04 percent on Wednesday.
• Yandex N.V. YNDX shares rose 4.7 percent to $36.67 in pre-market trading after gaining 3.00 percent on Wednesday.
• Adaptimmune Therapeutics plc ADAP rose 3.7 percent to $12.00 in pre-market trading after surging 4.71 percent on Wednesday.
• Delta Air Lines, Inc. DAL rose 3 percent to $52.97 in pre-market trading as the company reported better-than-expected profit for its first quarter.
• Zumiez Inc ZUMZ shares rose 2 percent to $25.80 in pre-market trading after the company reported a 14.7 percent year-over-year rise in its March sales. Comps were up 12.6 percent in the month.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Bed Bath & Beyond Inc. BBBY fell 17.2 percent to $17.80 in pre-market trading. Bed Bath & Beyond reported upbeat earnings for its fourth quarter, but issued weak FY18 guidance. Comps were down 0.6 percent in the quarter.
• China Advanced Construction Materials Group, Inc. CADC shares fell 15.2 percent to $2.80 in pre-market trading after climbing 40.43 percent on Wednesday.
• PolarityTE, Inc. COOL shares fell 12.6 percent to $16.01 in pre-market trading after announcing a common stock offering.
• Odyssey Marine Exploration, Inc. OMEX fell 9 percent to $9.00 in pre-market trading after rising 7.38 percent on Wednesday.
• AXT, Inc. AXTI shares fell 6.2 percent to $6.85 in pre-market trading after the company lowered its Q1 sales guidance.
• Apogee Enterprises, Inc. APOG fell 5.8 percent to $40.00 in pre-market trading after reporting Q4 results.
• Cosan Limited CZZ shares fell 5 percent to $10.25 in pre-market trading after rising 2.47 percent on Wednesday.
• ShiftPixy, Inc. PIXY fell 4.4 percent to $3.45 in pre-market trading after rising 15.71 percent on Wednesday.
• Semiconductor Manufacturing International Corporation SMI fell 4.3 percent to $6.25 in pre-market trading.
• Daqo New Energy Corp. DQ fell 3.8 percent to $57.00 in pre-market trading after announcing a 2 million ADS offering.
• Apellis Pharmaceuticals, Inc. APLS fell 3.6 percent to $26.30 after surging 8.04 percent on Wednesday.